LearnGlossaryMarketStocksSuperinvestorsSign in

CDNA

CareDx, Inc

Healthcare · $3.3B market cap

Verdict

We can't put a fair value on CDNA right now. Its earnings are too small compared with its share price for an earnings-based value to mean anything.

Business quality

2 of 5 clear the 10% bar. What are the Big Five?

Earnings per share growth—?
Equity per share growth16.3% a year✓
Sales growth29.6% a year✓
Free cash flow growth9.4% a year✗
Return on invested capital-16.4%✗

Follow CDNA

Track it on your watchlist and see the full analysis. Free.

Create a free account

Superinvestors

1 of the investors we track holds CDNA. Who we track

First Eagle Investment Management

First Eagle Investment Management · as of Q2 2026

$17.1M

598,497 shares

About CareDx, Inc

CareDx, Inc. is a global innovator specializing in the discovery, development, and commercialization of diagnostic and management tools designed for transplant recipients and their healthcare providers. The company's extensive portfolio features a range of specialized diagnostic solutions for organ monitoring, including: AlloSure Kidney, AlloSure Heart, and AlloSure Lung: Advanced tests employing donor-derived…

Medical - Diagnostics & Research

Fair value and Payback Price are estimates from the company's reported financials, not investment advice. Prices as of the close of Oct 3, 2026. How the Payback Price works